 |
|
|
| |
Durable Efficacy of Two-Drug Regimen of DTG + 3TC in Antiretroviral Treatment-Naive Adults With HIV-1 Infection at 96 Weeks: Subgroup Analyses in the GEMINI Studies
|
| |
| |
Reported by Jules Levin
ID Week 2019 Oct 2-6 Wash DC
Jean van Wyk,1 Choy Man,2 Jörg Sievers,1 Rimgaile Urbaityte,3 Mark Underwood,2
Allan Tenorio,2 Keith Pappa,2 Brian Wynne,2 Kimberly Smith,2 Martin Gartland2
1ViiV Healthcare, Brentford, United Kingdom; 2ViiV Healthcare, Research Triangle Park, NC, United States; 3GlaxoSmithKline, Stockley Park, United Kingdom
|
| |
|
|
|
|
|
